Obsidian Therapeutics Statistics
NASDAQ: OBXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
12.00-0.15 (-1.23%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Obsidian Therapeutics by the numbers
Obsidian Therapeutics has a market capitalization of $741.3 million based on 61.77M shares outstanding. With trailing EPS of $-6.52, Obsidian Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 12.5% below its 50-day average and 27.0% below its 200-day average.
Average daily trading volume is 511.50K shares, or about $6.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
OBX valuation vs. peer median
| Metric | OBX | Peer median | Difference |
|---|---|---|---|
| Market cap | $741.29M | $766.56M | -3% |
| Avg. volume | 511.50K | 2.28M | -78% |
Peer median across 8 companies: IVA, ARDX, RIGL, ORIC, COLL, IRWD, SNDX, VSTM.
Valuation
- Market cap
- $741.29M
- EPS (TTM)
- $-6.52
- Shares outstanding
- 61.77M
Price and trading
- Previous close
- 12.15
- Open
- 12.22
- Day range
- 11.76 – 12.30
- 52-week range
- 9.60 – 49.97
- Beta
- —
- Volume
- 336.50K
- Average volume
- 511.50K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 741.29M
- Forward Pe
- -5.63
- Eps
- -6.52
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 49.97
- Week52 Low
- 9.60
- Avg Volume
- 511.50K
- Shares Outstanding
- 61.77M
- Ma50
- 13.72
- Ma200
- 16.43
- Pct From52w High
- -75.99%
- Pct From52w Low
- 25.00%